Cargando…
12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations
BACKGROUND: Two formulations of investigational bivalent Clostridioides (Clostridium) difficile vaccine (QS-21 adjuvanted toxoid and toxoid-alone) were assessed for safety and immunogenicity in randomized studies in healthy adults 50–85 years of age. METHODS: The Phase 1 study of QS-21 adjuvanted to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776042/ http://dx.doi.org/10.1093/ofid/ofaa439.057 |